MCC1D
MCID: 3MT011
MIFTS: 31

3-Methylcrotonyl-Coa Carboxylase 1 Deficiency (MCC1D)

Categories: Genetic diseases, Rare diseases

Aliases & Classifications for 3-Methylcrotonyl-Coa Carboxylase 1 Deficiency

MalaCards integrated aliases for 3-Methylcrotonyl-Coa Carboxylase 1 Deficiency:

Name: 3-Methylcrotonyl-Coa Carboxylase 1 Deficiency 57 13
3 Methylcrotonyl-Coa Carboxylase 1 Deficiency 53 29 6 40
Methylcrotonylglycinuria Type I 57 75
Mcc1 Deficiency 57 75
Mccd Type 1 57 75
Mcc1d 57 75
3-Methylcrotonoyl-Coa Carboxylase 1 Deficiency 75
3-Methylcrotonyl Coa Carboxylase 1 Deficiency 73
3 Methylcrotonyl-Coa Carboxylase Deficiency 53
3 Alpha Methylcrotonylglycinuria 1 53
3-Methylcrotonyl-Coa Carboxylase 1 13
3-Methylcrotonylglycinuria Type I 75
3-Methylcrotonylglycinuria I 57
3 Methylcrotonylglycinuria 53
Mcc 1 Deficiency 53
Mcgi 75

Characteristics:

OMIM:

57
Inheritance:
autosomal recessive

Miscellaneous:
highly variable phenotype
may present in infancy with episodes of severe metabolic decompensation
may be present in asymptomatic adults
not responsive to biotin treatment
genetic heterogeneity (see mcc2 deficiency )
detected in 1/50,000 in neonatal screening programs


HPO:

32
3-methylcrotonyl-coa carboxylase 1 deficiency:
Onset and clinical course phenotypic variability
Inheritance heterogeneous autosomal recessive inheritance


Classifications:



Summaries for 3-Methylcrotonyl-Coa Carboxylase 1 Deficiency

UniProtKB/Swiss-Prot : 75 3-methylcrotonoyl-CoA carboxylase 1 deficiency: An autosomal recessive disorder of leucine catabolism. The phenotype is variable, ranging from neonatal onset with severe neurological involvement to asymptomatic adults. There is a characteristic organic aciduria with massive excretion of 3-hydroxyisovaleric acid and 3- methylcrotonylglycine, usually in combination with a severe secondary carnitine deficiency.

MalaCards based summary : 3-Methylcrotonyl-Coa Carboxylase 1 Deficiency, also known as 3 methylcrotonyl-coa carboxylase 1 deficiency, is related to 3-methylcrotonyl-coa carboxylase deficiency, and has symptoms including seizures, vomiting and lethargy. An important gene associated with 3-Methylcrotonyl-Coa Carboxylase 1 Deficiency is MCCC1 (Methylcrotonoyl-CoA Carboxylase 1). Affiliated tissues include cortex, and related phenotypes are intellectual disability and seizures

Description from OMIM: 210200

Related Diseases for 3-Methylcrotonyl-Coa Carboxylase 1 Deficiency

Diseases related to 3-Methylcrotonyl-Coa Carboxylase 1 Deficiency via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 3-methylcrotonyl-coa carboxylase deficiency 11.6

Symptoms & Phenotypes for 3-Methylcrotonyl-Coa Carboxylase 1 Deficiency

Symptoms via clinical synopsis from OMIM:

57
Neurologic Central Nervous System:
seizures
hyperreflexia
coma
lethargy
opisthotonus
more
Abdomen Gastrointestinal:
vomiting
feeding difficulties

Metabolic Features:
metabolic acidosis, episodic
metabolic decompensation precipitated by illness
hypoglycemia, acute

Abdomen Liver:
macro- and microvesicular steatosis, acute

Growth Other:
failure to thrive

Muscle Soft Tissue:
hypotonia

Respiratory:
apnea, acute

Laboratory Abnormalities:
urinary excretion of 3-methylcrotonylglycine, chronic
urinary excretion of 3-hydroxyisovaleric acid, chronic
secondary decrease of plasma free carnitine
hyperammonemia, acute
ketonuria, acute
more

Clinical features from OMIM:

210200

Human phenotypes related to 3-Methylcrotonyl-Coa Carboxylase 1 Deficiency:

32 (show all 17)
# Description HPO Frequency HPO Source Accession
1 intellectual disability 32 HP:0001249
2 seizures 32 HP:0001250
3 muscular hypotonia 32 HP:0001252
4 hyperreflexia 32 HP:0001347
5 failure to thrive 32 HP:0001508
6 global developmental delay 32 HP:0001263
7 feeding difficulties in infancy 32 HP:0008872
8 vomiting 32 HP:0002013
9 hypoglycemia 32 HP:0001943
10 coma 32 HP:0001259
11 lethargy 32 HP:0001254
12 generalized hypotonia 32 HP:0001290
13 opisthotonus 32 HP:0002179
14 ketonuria 32 HP:0002919
15 acute hepatic steatosis 32 HP:0006573
16 episodic metabolic acidosis 32 HP:0004911
17 acute hyperammonemia 32 HP:0008281

UMLS symptoms related to 3-Methylcrotonyl-Coa Carboxylase 1 Deficiency:


seizures, vomiting, lethargy, opisthotonus

Drugs & Therapeutics for 3-Methylcrotonyl-Coa Carboxylase 1 Deficiency

Search Clinical Trials , NIH Clinical Center for 3-Methylcrotonyl-Coa Carboxylase 1 Deficiency

Genetic Tests for 3-Methylcrotonyl-Coa Carboxylase 1 Deficiency

Genetic tests related to 3-Methylcrotonyl-Coa Carboxylase 1 Deficiency:

# Genetic test Affiliating Genes
1 3 Methylcrotonyl-Coa Carboxylase 1 Deficiency 29 MCCC1

Anatomical Context for 3-Methylcrotonyl-Coa Carboxylase 1 Deficiency

MalaCards organs/tissues related to 3-Methylcrotonyl-Coa Carboxylase 1 Deficiency:

41
Cortex

Publications for 3-Methylcrotonyl-Coa Carboxylase 1 Deficiency

Articles related to 3-Methylcrotonyl-Coa Carboxylase 1 Deficiency:

(show all 43)
# Title Authors Year
1
3-Methylcrotonyl-CoA carboxylase deficiency: Mutational spectrum derived from comprehensive newborn screening. ( 27601257 )
2016
2
Primary and maternal 3-methylcrotonyl-CoA carboxylase deficiency: insights from the Israel newborn screening program. ( 26566957 )
2016
3
3-Methylcrotonyl-CoA carboxylase deficiency: to screen or not to screen? ( 26660660 )
2016
4
Is L-Carnitine Supplementation Beneficial in 3-Methylcrotonyl-CoA Carboxylase Deficiency? ( 25732994 )
2015
5
An asymptomatic mother diagnosed with 3-methylcrotonyl-CoA carboxylase deficiency after newborn screening. ( 25381946 )
2014
6
Neurochemical evidence that the metabolites accumulating in 3-methylcrotonyl-CoA carboxylase deficiency induce oxidative damage in cerebral cortex of young rats. ( 23053545 )
2013
7
Analysis of cases of 3-methylcrotonyl CoA carboxylase deficiency (3-MCCD) in the California newborn screening program reported in the state database. ( 24103308 )
2013
8
3-methylcrotonyl-CoA carboxylase deficiency: clinical, biochemical, enzymatic and molecular studies in 88 individuals. ( 22642865 )
2012
9
Mutational spectrum in eight Korean patients with 3-methylcrotonyl- CoA carboxylase deficiency. ( 22150417 )
2012
10
A single mutation in MCCC1 or MCCC2 as a potential cause of positive screening for 3-methylcrotonyl-CoA carboxylase deficiency. ( 22264772 )
2012
11
Cryptic exon activation by disruption of exon splice enhancer: novel mechanism causing 3-methylcrotonyl-CoA carboxylase deficiency. ( 19706617 )
2009
12
3-Methylcrotonyl-CoA carboxylase deficiency: phenotypic variability in a family. ( 19339287 )
2009
13
Anesthetic management of a patient with 3-methylcrotonyl-CoA carboxylase deficiency. ( 18633047 )
2008
14
Recurrent attacks of status epilepticus as predominant symptom in 3-methylcrotonyl-CoA carboxylase deficiency. ( 17869468 )
2008
15
A Delphi-based consensus clinical practice protocol for the diagnosis and management of 3-methylcrotonyl CoA carboxylase deficiency. ( 18155630 )
2008
16
3-methylcrotonyl-CoA carboxylase deficiency and severe multiple sclerosis. ( 17275669 )
2007
17
Novel mutations in five Japanese patients with 3-methylcrotonyl-CoA carboxylase deficiency. ( 17968484 )
2007
18
Newborn screening for 3-methylcrotonyl-CoA carboxylase deficiency: population heterogeneity of MCCA and MCCB mutations and impact on risk assessment. ( 16835865 )
2006
19
3-Methylcrotonyl-CoA carboxylase deficiency. A long-term outcome. ( 16680273 )
2006
20
3-Methylcrotonyl-CoA carboxylase deficiency: metabolic decompensation in a noncompliant child detected through newborn screening. ( 17142544 )
2006
21
Molecular mechanism of dominant expression in 3-methylcrotonyl-CoA carboxylase deficiency. ( 15868465 )
2005
22
Severe hypoglycaemia in isolated 3-methylcrotonyl-CoA carboxylase deficiency; a rare, severe clinical presentation. ( 16435207 )
2005
23
3-Methylcrotonyl-CoA carboxylase deficiency: mutation analysis in 28 probands, 9 symptomatic and 19 detected by newborn screening. ( 16010683 )
2005
24
Consanguineous 3-methylcrotonyl-CoA carboxylase deficiency: early-onset necrotizing encephalopathy with lethal outcome. ( 15877210 )
2005
25
Fungal metabolic model for 3-methylcrotonyl-CoA carboxylase deficiency. ( 14612443 )
2004
26
Isolated 3-methylcrotonyl-CoA carboxylase deficiency: evidence for an allele-specific dominant negative effect and responsiveness to biotin therapy. ( 15359379 )
2004
27
Evaluation of 3-methylcrotonyl-CoA carboxylase deficiency detected by tandem mass spectrometry newborn screening. ( 12872837 )
2003
28
Leukodystrophy and CSF purine abnormalities associated with isolated 3-methylcrotonyl-CoA carboxylase deficiency. ( 11893004 )
2002
29
The molecular basis of human 3-methylcrotonyl-CoA carboxylase deficiency. ( 11181649 )
2001
30
Cloning of the human MCCA and MCCB genes and mutations therein reveal the molecular cause of 3-methylcrotonyl-CoA: carboxylase deficiency. ( 11406611 )
2001
31
3-methylcrotonyl-CoA carboxylase deficiency in an infant with cardiomyopathy, in her brother with developmental delay and in their asymptomatic father. ( 11131348 )
2000
32
Metabolic stroke in isolated 3-methylcrotonyl-CoA carboxylase deficiency. ( 10485305 )
1999
33
Late-infantile 3-methylcrotonyl-CoA carboxylase deficiency presenting as global developmental delay. ( 9584271 )
1998
34
Partial 3-methylcrotonyl-CoA carboxylase deficiency in an infant with fatal outcome due to progressive respiratory failure. ( 9537490 )
1998
35
Isolated 3-methylcrotonyl-CoA carboxylase deficiency in a 15-year-old girl. ( 9187484 )
1997
36
Isolated biotin-resistant 3-methylcrotonyl-CoA carboxylase deficiency: long-term outcome in a case with neonatal onset. ( 8831079 )
1996
37
3-Hydroxyisovalerylcarnitine in 3-methylcrotonyl-CoA carboxylase deficiency. ( 8598640 )
1995
38
Glycine and L-carnitine therapy in 3-methylcrotonyl-CoA carboxylase deficiency. ( 7474896 )
1995
39
Isolated (biotin-resistant) 3-methylcrotonyl-CoA carboxylase deficiency: four sibs devoid of pathology. ( 8598650 )
1995
40
Isolated 3-methylcrotonyl-CoA carboxylase deficiency in a 16-month-old child. ( 1779635 )
1991
41
Isolated biotin-resistant 3-methylcrotonyl-CoA carboxylase deficiency presenting as a Reye syndrome-like illness. ( 2515383 )
1989
42
Isolated biotin-resistant 3-methylcrotonyl CoA carboxylase deficiency presenting with life-threatening hypoglycaemia. ( 6441868 )
1984
43
Isolated biotin-resistant 3-methylcrotonyl-CoA carboxylase deficiency in two sibs. ( 7128647 )
1982

Variations for 3-Methylcrotonyl-Coa Carboxylase 1 Deficiency

UniProtKB/Swiss-Prot genetic disease variations for 3-Methylcrotonyl-Coa Carboxylase 1 Deficiency:

75 (show all 33)
# Symbol AA change Variation ID SNP ID
1 MCCC1 p.Ala289Val VAR_012785 rs132611407
2 MCCC1 p.Met325Arg VAR_012786 rs119103212
3 MCCC1 p.Arg385Ser VAR_012787 rs119103213
4 MCCC1 p.Leu437Pro VAR_012788 rs119103215
5 MCCC1 p.Asp532His VAR_012790 rs119103214
6 MCCC1 p.Ser535Phe VAR_012791 rs119103216
7 MCCC1 p.Cys276Arg VAR_067197 rs773433541
8 MCCC1 p.Arg281Gln VAR_067198 rs754437245
9 MCCC1 p.Gly46Glu VAR_072486 rs199517715
10 MCCC1 p.Asn56Lys VAR_072487 rs105752069
11 MCCC1 p.Met65Leu VAR_072488
12 MCCC1 p.Gln123His VAR_072489
13 MCCC1 p.Ile125Met VAR_072490
14 MCCC1 p.Glu134Lys VAR_072491
15 MCCC1 p.Met160Arg VAR_072492
16 MCCC1 p.Gly180Val VAR_072493
17 MCCC1 p.Ser187Pro VAR_072494 rs757362635
18 MCCC1 p.Arg232Trp VAR_072495 rs727504004
19 MCCC1 p.Ala268Asp VAR_072496
20 MCCC1 p.Glu288Gly VAR_072497 rs746500530
21 MCCC1 p.Ala291Val VAR_072498 rs201041864
22 MCCC1 p.Gln372Pro VAR_072499 rs755328329
23 MCCC1 p.Gly379Asp VAR_072500
24 MCCC1 p.Gly379Ser VAR_072501 rs887877405
25 MCCC1 p.His380Pro VAR_072502 rs794727036
26 MCCC1 p.Ile434Met VAR_072503 rs376289130
27 MCCC1 p.Val439Met VAR_072504 rs398124352
28 MCCC1 p.Ile460Met VAR_072505 rs119103218
29 MCCC1 p.Tyr79Cys VAR_077284
30 MCCC1 p.Ser120Phe VAR_077285
31 MCCC1 p.Gly130Ser VAR_077286 rs202197951
32 MCCC1 p.Gly209Val VAR_077287 rs186209189
33 MCCC1 p.Arg444His VAR_077290 rs768785753

ClinVar genetic disease variations for 3-Methylcrotonyl-Coa Carboxylase 1 Deficiency:

6 (show top 50) (show all 132)
# Gene Variation Type Significance SNP ID Assembly Location
1 MCCC1 NM_020166.4(MCCC1): c.974T> G (p.Met325Arg) single nucleotide variant Pathogenic/Likely pathogenic rs119103212 GRCh37 Chromosome 3, 182763310: 182763310
2 MCCC1 NM_020166.4(MCCC1): c.974T> G (p.Met325Arg) single nucleotide variant Pathogenic/Likely pathogenic rs119103212 GRCh38 Chromosome 3, 183045522: 183045522
3 MCCC1 NM_020166.4(MCCC1): c.1155A> C (p.Arg385Ser) single nucleotide variant Pathogenic rs119103213 GRCh37 Chromosome 3, 182759467: 182759467
4 MCCC1 NM_020166.4(MCCC1): c.1155A> C (p.Arg385Ser) single nucleotide variant Pathogenic rs119103213 GRCh38 Chromosome 3, 183041679: 183041679
5 MCCC1 NM_020166.4(MCCC1): c.1594G> C (p.Asp532His) single nucleotide variant Pathogenic rs119103214 GRCh37 Chromosome 3, 182755006: 182755006
6 MCCC1 NM_020166.4(MCCC1): c.1594G> C (p.Asp532His) single nucleotide variant Pathogenic rs119103214 GRCh38 Chromosome 3, 183037218: 183037218
7 MCCC1 NM_020166.4(MCCC1): c.1310T> C (p.Leu437Pro) single nucleotide variant Pathogenic rs119103215 GRCh37 Chromosome 3, 182756881: 182756881
8 MCCC1 NM_020166.4(MCCC1): c.1310T> C (p.Leu437Pro) single nucleotide variant Pathogenic rs119103215 GRCh38 Chromosome 3, 183039093: 183039093
9 MCCC1 NM_020166.4(MCCC1): c.1604C> T (p.Ser535Phe) single nucleotide variant Pathogenic rs119103216 GRCh37 Chromosome 3, 182751856: 182751856
10 MCCC1 NM_020166.4(MCCC1): c.1604C> T (p.Ser535Phe) single nucleotide variant Pathogenic rs119103216 GRCh38 Chromosome 3, 183034068: 183034068
11 MCCC1 NM_020166.4(MCCC1): c.2079delA (p.Val694Terfs) deletion Pathogenic rs119103217 GRCh37 Chromosome 3, 182733325: 182733325
12 MCCC1 NM_020166.4(MCCC1): c.2079delA (p.Val694Terfs) deletion Pathogenic rs119103217 GRCh38 Chromosome 3, 183015537: 183015537
13 MCCC1 NM_020166.4(MCCC1): c.1380T> G (p.Ile460Met) single nucleotide variant Pathogenic rs119103218 GRCh37 Chromosome 3, 182755220: 182755220
14 MCCC1 NM_020166.4(MCCC1): c.1380T> G (p.Ile460Met) single nucleotide variant Pathogenic rs119103218 GRCh38 Chromosome 3, 183037432: 183037432
15 MCCC1 NM_020166.4(MCCC1): c.1074delG (p.Trp358Cysfs) deletion Pathogenic rs398124350 GRCh37 Chromosome 3, 182763210: 182763210
16 MCCC1 NM_020166.4(MCCC1): c.1074delG (p.Trp358Cysfs) deletion Pathogenic rs398124350 GRCh38 Chromosome 3, 183045422: 183045422
17 MCCC1 NM_020166.4(MCCC1): c.1277T> C (p.Val426Ala) single nucleotide variant Likely pathogenic rs398124351 GRCh37 Chromosome 3, 182756914: 182756914
18 MCCC1 NM_020166.4(MCCC1): c.1277T> C (p.Val426Ala) single nucleotide variant Likely pathogenic rs398124351 GRCh38 Chromosome 3, 183039126: 183039126
19 MCCC1 NM_020166.4(MCCC1): c.1315G> A (p.Val439Met) single nucleotide variant Uncertain significance rs398124352 GRCh37 Chromosome 3, 182756876: 182756876
20 MCCC1 NM_020166.4(MCCC1): c.1315G> A (p.Val439Met) single nucleotide variant Uncertain significance rs398124352 GRCh38 Chromosome 3, 183039088: 183039088
21 MCCC1 NM_020166.4(MCCC1): c.1905delA (p.Lys635Asnfs) deletion Pathogenic rs727504001 GRCh37 Chromosome 3, 182737990: 182737990
22 MCCC1 NM_020166.4(MCCC1): c.1905delA (p.Lys635Asnfs) deletion Pathogenic rs727504001 GRCh38 Chromosome 3, 183020202: 183020202
23 MCCC1 NM_020166.4(MCCC1): c.1614G> A (p.Ser538=) single nucleotide variant Conflicting interpretations of pathogenicity rs34749281 GRCh37 Chromosome 3, 182751846: 182751846
24 MCCC1 NM_020166.4(MCCC1): c.1614G> A (p.Ser538=) single nucleotide variant Conflicting interpretations of pathogenicity rs34749281 GRCh38 Chromosome 3, 183034058: 183034058
25 MCCC1 NM_020166.4(MCCC1): c.1526delG (p.Cys509Serfs) deletion Pathogenic rs727504002 GRCh37 Chromosome 3, 182755074: 182755074
26 MCCC1 NM_020166.4(MCCC1): c.1526delG (p.Cys509Serfs) deletion Pathogenic rs727504002 GRCh38 Chromosome 3, 183037286: 183037286
27 MCCC1 NM_020166.4(MCCC1): c.873G> A (p.Ala291=) single nucleotide variant Uncertain significance rs138794621 GRCh37 Chromosome 3, 182775099: 182775099
28 MCCC1 NM_020166.4(MCCC1): c.873G> A (p.Ala291=) single nucleotide variant Uncertain significance rs138794621 GRCh38 Chromosome 3, 183057311: 183057311
29 MCCC1 NM_020166.4(MCCC1): c.640-1G> A single nucleotide variant Pathogenic rs727504005 GRCh37 Chromosome 3, 182788909: 182788909
30 MCCC1 NM_020166.4(MCCC1): c.640-1G> A single nucleotide variant Pathogenic rs727504005 GRCh38 Chromosome 3, 183071121: 183071121
31 MCCC1 NM_020166.4(MCCC1): c.137-2A> G single nucleotide variant Pathogenic rs727504006 GRCh37 Chromosome 3, 182810335: 182810335
32 MCCC1 NM_020166.4(MCCC1): c.137-2A> G single nucleotide variant Pathogenic rs727504006 GRCh38 Chromosome 3, 183092547: 183092547
33 MCCC1 NM_020166.4(MCCC1): c.1114C> T (p.Gln372Ter) single nucleotide variant Pathogenic rs544349961 GRCh37 Chromosome 3, 182759508: 182759508
34 MCCC1 NM_020166.4(MCCC1): c.1114C> T (p.Gln372Ter) single nucleotide variant Pathogenic rs544349961 GRCh38 Chromosome 3, 183041720: 183041720
35 MCCC1 NM_020166.4(MCCC1): c.205A> T (p.Lys69Ter) single nucleotide variant Pathogenic rs147741073 GRCh37 Chromosome 3, 182810265: 182810265
36 MCCC1 NM_020166.4(MCCC1): c.205A> T (p.Lys69Ter) single nucleotide variant Pathogenic rs147741073 GRCh38 Chromosome 3, 183092477: 183092477
37 MCCC1 NM_020166.4(MCCC1): c.640-2A> G single nucleotide variant Pathogenic/Likely pathogenic rs772395858 GRCh37 Chromosome 3, 182788910: 182788910
38 MCCC1 NM_020166.4(MCCC1): c.640-2A> G single nucleotide variant Pathogenic/Likely pathogenic rs772395858 GRCh38 Chromosome 3, 183071122: 183071122
39 MCCC1 NM_020166.4(MCCC1): c.1193_1194delTG (p.Val398Glyfs) deletion Pathogenic rs796051985 GRCh38 Chromosome 3, 183041640: 183041641
40 MCCC1 NM_020166.4(MCCC1): c.1193_1194delTG (p.Val398Glyfs) deletion Pathogenic rs796051985 GRCh37 Chromosome 3, 182759428: 182759429
41 MCCC1 NM_020166.4(MCCC1): c.841C> T (p.Arg281Ter) single nucleotide variant Pathogenic rs185741664 GRCh38 Chromosome 3, 183057343: 183057343
42 MCCC1 NM_020166.4(MCCC1): c.841C> T (p.Arg281Ter) single nucleotide variant Pathogenic rs185741664 GRCh37 Chromosome 3, 182775131: 182775131
43 MCCC1 NM_020166.4(MCCC1): c.137G> A (p.Gly46Glu) single nucleotide variant Conflicting interpretations of pathogenicity rs199517715 GRCh38 Chromosome 3, 183092545: 183092545
44 MCCC1 NM_020166.4(MCCC1): c.137G> A (p.Gly46Glu) single nucleotide variant Conflicting interpretations of pathogenicity rs199517715 GRCh37 Chromosome 3, 182810333: 182810333
45 MCCC1 NM_020166.4(MCCC1): c.1772G> A (p.Ser591Asn) single nucleotide variant Likely benign rs569721834 GRCh38 Chromosome 3, 183022514: 183022514
46 MCCC1 NM_020166.4(MCCC1): c.1772G> A (p.Ser591Asn) single nucleotide variant Likely benign rs569721834 GRCh37 Chromosome 3, 182740302: 182740302
47 MCCC1 NM_020166.4(MCCC1): c.231G> A (p.Ala77=) single nucleotide variant Conflicting interpretations of pathogenicity rs144230304 GRCh38 Chromosome 3, 183092451: 183092451
48 MCCC1 NM_020166.4(MCCC1): c.231G> A (p.Ala77=) single nucleotide variant Conflicting interpretations of pathogenicity rs144230304 GRCh37 Chromosome 3, 182810239: 182810239
49 MCCC1 NM_020166.4(MCCC1): c.980C> G (p.Ser327Ter) single nucleotide variant Pathogenic rs750484977 GRCh37 Chromosome 3, 182763304: 182763304
50 MCCC1 NM_020166.4(MCCC1): c.980C> G (p.Ser327Ter) single nucleotide variant Pathogenic rs750484977 GRCh38 Chromosome 3, 183045516: 183045516

Expression for 3-Methylcrotonyl-Coa Carboxylase 1 Deficiency

Search GEO for disease gene expression data for 3-Methylcrotonyl-Coa Carboxylase 1 Deficiency.

Pathways for 3-Methylcrotonyl-Coa Carboxylase 1 Deficiency

GO Terms for 3-Methylcrotonyl-Coa Carboxylase 1 Deficiency

Sources for 3-Methylcrotonyl-Coa Carboxylase 1 Deficiency

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....